Les résultats indiquent que le psoriasis est associé à des niveaux significativement plus bas de vitamine D 25-hydroxy, à l’augmentation de l’inflammation systémique et du stress oxydatif en particulier dans les cas graves de la maladie. RÉFÉRENCE:
Veuillez lire l'article complet (en anglais seulement) : Abstract Psoriasis is a T-helper-1 (Th1)/Th17-mediated chronic inflammatory skin disease, characterised by hyperproliferation of keratinocytes. Psoriasis and cardiovascular disease share similar pathogenic mechanisms such as vascular endothelial cell dysfunction, oxidative stress and metabolic syndrome. 25-hydroxy vitamin D is an immune-regulatory hormone, with the ability to reduce cellular proliferation in psoriasis. Ischaemia-modified albumin (IMA) is a marker of oxidative stress. This study examined 25-hydroxy vitamin D, IMA and high-sensitivity C-reactive protein (hs-CRP) levels in patients with psoriasis, in comparison with healthy controls and their possible association with disease severity. A total of 43 cases of psoriasis and 43 controls were included in this cross-sectional study, and severity grading was performed according to psoriasis area severity index (PASI) scoring. Serum 25-hydroxy vitamin D, IMA and hs-CRP were evaluated in all study subjects. In psoriasis, 25-hydroxy vitamin D showed a significant decline, while hs-CRP and IMA levels were significantly elevated, as compared with controls. Serum 25-hydroxy vitamin D showed a significant negative correlation with PASI score. hs-CRP and IMA showed a significant positive correlation with PASI score. Significant negative correlation was observed between 25-hydroxy vitamin D and hs-CRP; 25-hydroxy vitamin D and IMA levels in psoriasis. The results indicate that psoriasis is associated with significantly lowered 25-hydroxy vitamin D levels, along with increased systemic inflammation and oxidative stress, especially in severe disease. Thus, vitamin D supplementation might reduce systemic inflammation and oxidative stress and help in delaying the pathogenesis of co-morbidities associated with psoriasis. Br J Biomed Sci. 2015;72(2):56-60. 25-hydroxy vitamin D and ischaemia-modified albumin levels in psoriasis and their association with disease severity. Chandrashekar L, Kumarit GR, Rajappa M, Revathy G, Munisamy M, Thappa DM. Les commentaires sont fermés.
|
AVIS IMPORTANT:
Veuillez prendre connaissance de cet avertissement et rappelez-vous que le site www.drsuciu.com ne saurait remplacer une consultation avec vos professionnels de la santé. L'information fournie sur le site web www.drsuciu.com est d'ordre général. Avant de prendre toute décision de nature médicale ou si vous avez des questions concernant votre état de santé personnel, adressez-vous à un professionnel de la santé qualifiée. D'aucune manière ces points de vue, commentaires et renseignements ne constituent une recommandation de traitement (préventif ou curatif), une ordonnance ou un diagnostic, ni ne doivent être considérés comme tels. Archives
Août 2017
|